Vanda Pharmaceuticals Inc. (VNDA)
USD 4.55
(-3.81%)
USD 4.55
(-3.81%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 12.8 Million | 31.98 Million | 64.21 Million | 51.77 Million | 45.94 Million | 29.98 Million |
| Net Income | 2.5 Million | 6.27 Million | 33.15 Million | 23.33 Million | 115.55 Million | 25.2 Million |
| Depreciation & Amortization | 3.01 Million | 2.73 Million | 2.84 Million | 2.86 Million | 2.89 Million | 2.95 Million |
| Deferred income taxes | -1.28 Million | 1.13 Million | 6.74 Million | 6.18 Million | -87.76 Million | -2.22 Million |
| Stock-based compensation | 14.04 Million | 16.27 Million | 15.37 Million | 13.36 Million | 13.45 Million | 11.66 Million |
| Change in working capital | -747 Thousand | 6.07 Million | 2.73 Million | 4.31 Million | 3.12 Million | -7.79 Million |
| Other non-cash items | -4.72 Million | -507 Thousand | 3.36 Million | 1.7 Million | -1.31 Million | 167 Thousand |
| Investing Cash Flow | -12.05 Million | 49.92 Million | -76.69 Million | -41.49 Million | -68.3 Million | -109.66 Million |
| Investments in PPE | -383 Thousand | -679 Thousand | -552 Thousand | -1.79 Million | -1.01 Million | -25.36 Million |
| Acquisitions | -100.66 Million | -50.6 Million | -12 Thousand | -229 Thousand | 67.29 Million | 25 Million |
| Investment purchases | -512.6 Million | -349.25 Million | -420.46 Million | -346.62 Million | -394.51 Million | -282.39 Million |
| Sales/Maturities of investments | 601.59 Million | 399.86 Million | 344.31 Million | 306.91 Million | 327.22 Million | 198.1 Million |
| Other Investing Activities | 88.99 Million | 50.6 Million | 12 Thousand | 229 Thousand | -67.29 Million | -25 Million |
| Financing Cash Flow | - | 734 Thousand | 3.55 Million | 5.63 Million | 6.26 Million | 107.12 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 734 Thousand | 3.55 Million | 5.63 Million | 6.26 Million | 107.12 Million |
| Other Financing Activities | - | 734 Thousand | 3.55 Million | 5.63 Million | 6.26 Million | 107.12 Million |
| Accounts receivables | -707 Thousand | -1.08 Million | -2.46 Million | -3.76 Million | 2.34 Million | -11.2 Million |
| Accounts payables | -10.98 Million | 11.79 Million | 3.04 Million | 7.82 Million | 744 Thousand | -4.87 Million |
| Inventory | -771 Thousand | -4.47 Million | -2.23 Million | -2.87 Million | -722 Thousand | 70 Thousand |
| Other working capital | 11.71 Million | -151 Thousand | 4.39 Million | 3.13 Million | 761 Thousand | 8.22 Million |
| Cash at beginning of period | 135.02 Million | 52.59 Million | 61.61 Million | 45.65 Million | 61.74 Million | 34.33 Million |
| Cash at end of period | 135.82 Million | 135.49 Million | 52.59 Million | 61.61 Million | 45.65 Million | 61.74 Million |
| Capital Expenditure | -383 Thousand | -679 Thousand | -552 Thousand | -1.79 Million | -1.01 Million | -25.36 Million |
| Effect of forex changes on cash | 47 Thousand | 265 Thousand | -91 Thousand | 53 Thousand | -1000.00 | -38 Thousand |
| Net cash flow / Change in cash | 792 Thousand | 82.9 Million | -9.02 Million | 15.96 Million | -16.09 Million | 27.41 Million |
| Free Cash Flow | 12.41 Million | 31.3 Million | 63.66 Million | 49.98 Million | 44.92 Million | 4.61 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.51 Million | -4.14 Million | -2.4 Million | 2.5 Million | 137 Thousand | 1.52 Million |
| Depreciation & Amortization | 1.96 Million | 2.22 Million | 1.15 Million | 3.01 Million | 580 Thousand | 602 Thousand |
| Deferred income taxes | -1.23 Million | -246 Thousand | -7.48 Million | -1.28 Million | 2.72 Million | 1.45 Million |
| Stock-based compensation | 2.98 Million | 3.58 Million | 3.27 Million | 14.04 Million | 3.16 Million | 3.24 Million |
| Change in working capital | -4.61 Million | 6.97 Million | 2.82 Million | -747 Thousand | -6.77 Million | -18.82 Million |
| Other non-cash items | 7.16 Million | 8.6 Million | -1.09 Million | -4.72 Million | -1.88 Million | -1.21 Million |
| Investing Cash Flow | -15.26 Million | -18.21 Million | -43.78 Million | -12.05 Million | 35.32 Million | -190.89 Million |
| Investments in PPE | -108 Thousand | -7000.00 | -253 Thousand | -383 Thousand | -24 Thousand | -55 Thousand |
| Acquisitions | -1.52 Million | -2.7 Million | -100.66 Million | -100.66 Million | -35.35 Million | 190.83 Million |
| Investment purchases | -112.63 Million | -76 Million | -54.97 Million | -512.6 Million | -46.64 Million | -247.93 Million |
| Sales/Maturities of investments | 99 Million | 60.5 Million | 112.11 Million | 601.59 Million | 82 Million | 57.09 Million |
| Other Investing Activities | -1.52 Million | -2.7 Million | 57.13 Million | 88.99 Million | 35.35 Million | -190.83 Million |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | -5.16 Million | -2.58 Million | -4.83 Million | -707 Thousand | 4.32 Million | -9.1 Million |
| Accounts payables | 3.13 Million | 1.16 Million | 3.33 Million | -10.98 Million | -280 Thousand | -3.24 Million |
| Inventory | 263 Thousand | 29 Thousand | -427 Thousand | -771 Thousand | -554 Thousand | 136 Thousand |
| Other working capital | -2.85 Million | 8.37 Million | 4.75 Million | 11.71 Million | -10.27 Million | -6.62 Million |
| Cash at beginning of period | 125.15 Million | 135.82 Million | 183.65 Million | 135.02 Million | 150.5 Million | 354.64 Million |
| Cash at end of period | 102.95 Million | 125.15 Million | 136.29 Million | 135.82 Million | 183.65 Million | 150.5 Million |
| Capital Expenditure | -108 Thousand | -7000.00 | -253 Thousand | -383 Thousand | -24 Thousand | -55 Thousand |
| Effect of forex changes on cash | -15 Thousand | -14 Thousand | 150 Thousand | 47 Thousand | -122 Thousand | -26 Thousand |
| Net cash flow / Change in cash | -22.2 Million | -10.66 Million | -47.36 Million | 792 Thousand | 33.15 Million | -204.14 Million |
| Free Cash Flow | -7.03 Million | 7.56 Million | -3.98 Million | 12.41 Million | -2.07 Million | -13.27 Million |
0J1G
3021
JWL
3816
FNMAS
IDP